Barrie Chubb

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Placebo Controlled

Metabolic Syndrome

Bariatric Surgery

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

The European journal of health economics : HEPAC : health economics in prevention and care

This page only lists publications with an associated author ORCID identifier.

Publications

Ildiko Lingvay, Andrei-Mircea Catarig, Jack Lawson, Barrie Chubb, Anders Gorst-Rasmussen, Lyndon Marc Evans
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal-Bolus Insulin in Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)
Adie Viljoen, Barrie Chubb, Samuel J P Malkin, Sasha Berry, Barnaby Hunt, Stephen C Bain
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Lyndon Marc Evans, Barrie Chubb, Samuel Joseph Paul Malkin, Sasha Berry, Jack Lawson, Barnaby Hunt
Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11. Diabetes, obesity & metabolism (2022)
Barrie Chubb, Palvi Gupta, Jatin Gupta, Solomon Nuhoho, Klaus Kallenbach, Michelle Orme
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (5) (2021)
Richard E Pratley, Andrei-Mircea Catarig, Ildiko Lingvay, Adie Viljoen, Abby Paine, Jack Lawson, Barrie Chubb, Anders Gorst-Rasmussen, Nino Miresashvili
An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg. Diabetes, obesity & metabolism 23 (11) (2021)